Fosun Pharmaceutical among five Chinese firms licensed to produce generic version of Pfizer’s oral Covid-19 drug

• The agreements came after China for the first time imported Pfizer’s fully-packaged Covid-19 drug Paxlovid
• The five Chinese drug makers were among 35 firms to sign non-exclusive sublicensing agreements with the United Nations-backed MPP